— Know what they know.
Not Investment Advice

SMLR NASDAQ

Semler Scientific, Inc.
1W: -6.8% 1M: -22.6% 3M: -50.7% 1Y: -75.8% 3Y: -51.6% 5Y: -83.3%
$20.33
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Medical - Devices · $310.7M mcap · 15M float · 4.27% daily turnover · Short 49% of daily vol

Balance Sheet Trends

Total Assets
$240M +207.2% ▲
5Y CAGR: +67.3%
Total Liabilities
$9M +44.8% ▲
5Y CAGR: +11.7%
Shareholders Equity
$231M +221.4% ▲
5Y CAGR: +77.6%
Cash & Investments
$15M -73.9% ▼
5Y CAGR: +14.0%
Total Debt
$70K -56.2% ▼
Net Debt
-$9M +84.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$22M$37M$23M$57M$9M
Short-Term Investments$0$0$20M$0$6M
Cash & ST Investments$22M$37M$43M$57M$15M
Net Receivables$3M$4M$4M$6M$4M
Inventory$340K$550K$469K$445K$358K
Other Current Assets$0$0$0$2M$3M
Total Current Assets$27M$46M$49M$66M$23M
Property, Plant & Equip.$2M$2M$3M$3M$2M
Goodwill & Intangibles$0$0$0$0$215M
Long-Term Investments$3M$821K$6M$6M$512K
Other Non-Current Assets$418K$332K$3M$270K$85K
Total Non-Current Assets$8M$5M$14M$12M$217M
Total Assets$35M$51M$63M$78M$240M
— Liabilities —
Accounts Payable$677K$443K$835K$402K$140K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$963K$921K$1M$1M$774K
Other Current Liabilities$2M$523K$2M$2M$4M
Total Current Liabilities$5M$5M$7M$6M$6M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$332K$0$0$0$0
Total Non-Current Liabilities$332K$245K$160K$70K$3M
Total Liabilities$5M$5M$7M$6M$9M
— Equity —
Common Stock$7K$7K$7K$7K$9K
Retained Earnings$8M$25M$39M$60M$101M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$30M$46M$56M$72M$231M
Total Liabilities & Equity$35M$51M$63M$78M$240M
— Key Metrics —
Total Debt$0$325K$245K$160K$70K
Net Debt-$22M-$37M-$23M-$57M-$9M
Total Investments$3M$821K$26M$6M$7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms